1,057 filings
Page 10 of 53
10-Q
2022 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
4 Nov 22
1:19pm
4
Jay S. Duker
3 Nov 22
EyePoint Pharmaceuticals / Jay S. Duker ownership change
8:38am
8-K
EYPT
EyePoint Pharmaceuticals Inc
2 Nov 22
EyePoint Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
11 Oct 22
Termination of a Material Definitive Agreement
5:22pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
29 Sep 22
Other Events
7:05am
DEFA14A
EYPT
EyePoint Pharmaceuticals Inc
28 Sep 22
Additional proxy soliciting materials
4:12pm
DEF 14A
EYPT
EyePoint Pharmaceuticals Inc
Definitive proxy
28 Sep 22
4:11pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
28 Sep 22
Other Events
11:08am
PRE 14A
EYPT
EyePoint Pharmaceuticals Inc
Preliminary proxy
16 Sep 22
4:13pm
4
EYPT
EyePoint Pharmaceuticals Inc
9 Sep 22
EyePoint Pharmaceuticals / Jay S. Duker ownership change
4:19pm
4/A
EYPT
EyePoint Pharmaceuticals Inc
9 Sep 22
EyePoint Pharmaceuticals / Jay S. Duker ownership change
4:09pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
30 Aug 22
Other Events
4:22pm
10-Q
2022 Q2
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
5 Aug 22
2:13pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 Aug 22
EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
7:07am
8-K
EYPT
EyePoint Pharmaceuticals Inc
18 Jul 22
EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update
4:54pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
14 Jul 22
EyePoint Pharmaceuticals Appoints Karen Zaderej to Board of Directors
11:31am
4
Zaderej Karen L.
13 Jul 22
EyePoint Pharmaceuticals / Karen L. Zaderej ownership change
4:47pm
3
Zaderej Karen L.
13 Jul 22
EyePoint Pharmaceuticals / Karen L. Zaderej ownership change
4:46pm
4
Anthony P Adamis
27 Jun 22
EyePoint Pharmaceuticals / ANTHONY P ADAMIS ownership change
4:38pm
3
EYPT
EyePoint Pharmaceuticals Inc
27 Jun 22
EyePoint Pharmaceuticals / ANTHONY P ADAMIS ownership change
4:37pm